28 May 2021
Geneva – On the anniversary of the Solidarity Call to Action and the establishment of the C-TAP initiative, the Medicines Patent Pool (MPP) reaffirms its commitment and support to C-TAP by offering its expertise in licensing, to ensure that no one, wherever they live, are left behind when it comes to access to COVID-19 health technologies. The last year has seen an unprecedented response in developing tools to fight COVID-19. Today, there is still much to be done to ensure equitable access to COVID-19 health technologies, and C-TAP has a pivotal role in addressing challenges in global manufacturing and supply, along with universal access. MPP welcomes the growing support from partners for this very much needed initiative.
> Special press conference to mark the first anniversary of the COVID-19 Technology Access Pool
More on C-TAP
News & Press Releases » Events
Press and Media
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.
To date, MPP has signed agreements with 22 patent holders for 13 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, a cancer treatment, four long-acting technologies, a post-partum haemorrhage medicine, three oral antiviral treatments for COVID-19 and 16 COVID-19 technologies.
MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC), Government of Canada, the World Intellectual Property Organization (WIPO) and the Government of Flanders. MPP’s activities in COVID-19 are undertaken with the financial support of the Japanese Government, the French Ministry for Europe and Foreign Affairs, the German Agency for International Cooperation, and SDC.